2018 annual financial data
TG Therapeutics 2018 Net margin
Direct answer
Net margin was -114,132.89%.
Operating income was -174,400,000 USD and net income was -173,482,000 USD.
Operating cash flow was -128,925,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,000 USD
- Operating income
- -174,400,000 USD
- Net income
- -173,482,000 USD
- Operating cash flow
- -128,925,000 USD